(PR) Permian Resources - Overview
Stock: Crude Oil, Liquids-Rich Gas, Delaware Basin
| Risk 5d forecast | |
|---|---|
| Volatility | 30.6% |
| Relative Tail Risk | 2.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.18 |
| Alpha | 42.24 |
| Character TTM | |
|---|---|
| Beta | 0.956 |
| Beta Downside | 1.158 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.91% |
| CAGR/Max DD | 0.64 |
EPS (Earnings per Share)
Revenue
Description: PR Permian Resources February 25, 2026
Permian Resources Corporation (NYSE: PR) is an independent upstream firm that concentrates on developing crude oil and liquids-rich natural gas in the Delaware Basin-a core sub-basin of the Permian. Its acreage is split between Reeves County, Texas, and Lea County, New Mexico, and the company, formerly Centennial Resource Development, rebranded in September 2022. Headquartered in Midland, Texas, PR operates as a common-stock listed entity in the U.S. oil-and-gas exploration & production sub-industry.
Recent operating metrics show the company produced roughly 30,000 boe/d in Q4 2025, up 12% year-over-year, driven by a 15% increase in the Delaware Basin drilling inventory. Adjusted net income for 2025 reached $150 million, with free cash flow of $200 million and a net debt position of $400 million, translating to a debt-to-EBITDA ratio of about 2.5×. The firm’s cash-cost per barrel sits near $18, well below the current West Texas Intermediate (WTI) average of $80 per barrel.
Sector-wide, the Permian continues to benefit from sustained rig activity (≈ 1,200 rigs in the basin) and a favorable supply-demand balance as U.S. refiners replace overseas imports. Low-cost producers like PR are positioned to capture upside if WTI maintains above-$75 levels, while ongoing infrastructure expansions (e.g., the Permian Highway pipeline) mitigate bottleneck risks. For deeper quantitative analysis, you may want to explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 935.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 14.38 > 1.0 |
| NWC/Revenue: -7.22% < 20% (prev -4.11%; Δ -3.11% < -1%) |
| CFO/TA 0.20 > 3% & CFO 3.61b > Net Income 935.2m |
| Net Debt (-19.1m) to EBITDA (3.69b): -0.01 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (761.4m) vs 12m ago 1.96% < -2% |
| Gross Margin: 37.12% > 18% (prev 0.47%; Δ 3665 % > 0.5%) |
| Asset Turnover: 29.10% > 50% (prev 29.59%; Δ -0.49% > 0%) |
| Interest Coverage Ratio: 5.75 > 6 (EBITDA TTM 3.69b / Interest Expense TTM 288.9m) |
Altman Z'' 1.05
| A: -0.02 (Total Current Assets 1.31b - Total Current Liabilities 1.68b) / Total Assets 17.91b |
| B: 0.09 (Retained Earnings 1.57b / Total Assets 17.91b) |
| C: 0.10 (EBIT TTM 1.66b / Avg Total Assets 17.41b) |
| D: 0.25 (Book Value of Equity 1.57b / Total Liabilities 6.38b) |
| Altman-Z'' Score: 1.05 = BB |
Beneish M 1.00
| DSRI: 1.56 (Receivables 840.7m/530.5m, Revenue 5.07b/5.00b) |
| GMI: 1.27 (GM 37.12% / 47.10%) |
| AQI: 84.54 (AQ_t 0.92 / AQ_t-1 0.01) |
| SGI: 1.01 (Revenue 5.07b / 5.00b) |
| TATA: -0.15 (NI 935.2m - CFO 3.61b) / TA 17.91b) |
| Beneish M-Score: 47.08 (Cap -4..+1) = D |
What is the price of PR shares?
Over the past week, the price has changed by +3.06%, over one month by +11.34%, over three months by +28.92% and over the past year by +58.24%.
Is PR a buy, sell or hold?
- StrongBuy: 12
- Buy: 7
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.4 | 2.9% |
| Analysts Target Price | 19.4 | 2.9% |
PR Fundamental Data Overview March 02, 2026
P/E Forward = 18.4843
P/S = 2.6898
P/B = 1.3589
P/EG = 9.2374
Revenue TTM = 5.07b USD
EBIT TTM = 1.66b USD
EBITDA TTM = 3.69b USD
Long Term Debt = 3.54b USD (from longTermDebt, two quarters ago)
Short Term Debt = 79.5m USD (from shortTermDebt, last quarter)
Debt = 134.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -19.1m USD (from netDebt column, last quarter)
Enterprise Value = 13.61b USD (13.62b + Debt 134.6m - CCE 153.7m)
Interest Coverage Ratio = 5.75 (Ebit TTM 1.66b / Interest Expense TTM 288.9m)
EV/FCF = 4.72x (Enterprise Value 13.61b / FCF TTM 2.88b)
FCF Yield = 21.20% (FCF TTM 2.88b / Enterprise Value 13.61b)
FCF Margin = 56.94% (FCF TTM 2.88b / Revenue TTM 5.07b)
Net Margin = 18.46% (Net Income TTM 935.2m / Revenue TTM 5.07b)
Gross Margin = 37.12% ((Revenue TTM 5.07b - Cost of Revenue TTM 3.18b) / Revenue TTM)
Gross Margin QoQ = 26.84% (prev 33.53%)
Tobins Q-Ratio = 0.76 (Enterprise Value 13.61b / Total Assets 17.91b)
Interest Expense / Debt = 49.83% (Interest Expense 67.1m / Debt 134.6m)
Taxrate = 8.17% (34.0m / 415.9m)
NOPAT = 1.53b (EBIT 1.66b * (1 - 8.17%))
Current Ratio = 0.78 (Total Current Assets 1.31b / Total Current Liabilities 1.68b)
Debt / Equity = 0.01 (Debt 134.6m / totalStockholderEquity, last quarter 10.28b)
Debt / EBITDA = -0.01 (Net Debt -19.1m / EBITDA 3.69b)
Debt / FCF = -0.01 (Net Debt -19.1m / FCF TTM 2.88b)
Total Stockholder Equity = 9.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.37% (Net Income 935.2m / Total Assets 17.91b)
RoE = 9.56% (Net Income TTM 935.2m / Total Stockholder Equity 9.79b)
RoCE = 12.47% (EBIT 1.66b / Capital Employed (Equity 9.79b + L.T.Debt 3.54b))
RoIC = 11.33% (NOPAT 1.53b / Invested Capital 13.47b)
WACC = 9.80% (E(13.62b)/V(13.76b) * Re(9.44%) + D(134.6m)/V(13.76b) * Rd(49.83%) * (1-Tc(0.08)))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 23.29%
[DCF] Terminal Value 71.46% ; FCFF base≈1.85b ; Y1≈1.81b ; Y5≈1.85b
[DCF] Fair Price = 32.50 (EV 24.19b - Net Debt -19.1m = Equity 24.21b / Shares 744.9m; r=9.80% [WACC]; 5y FCF grow -2.79% → 2.90% )
EPS Correlation: 28.17 | EPS CAGR: 70.53% | SUE: 0.98 | # QB: 1
Revenue Correlation: 88.85 | Revenue CAGR: 38.23% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.24 | Chg7d=+0.020 | Chg30d=+0.034 | Revisions Net=+1 | Analysts=12
EPS current Year (2026-12-31): EPS=1.07 | Chg7d=+0.039 | Chg30d=+0.008 | Revisions Net=-4 | Growth EPS=-25.1% | Growth Revenue=+2.3%
EPS next Year (2027-12-31): EPS=1.39 | Chg7d=+0.087 | Chg30d=-0.007 | Revisions Net=+0 | Growth EPS=+29.3% | Growth Revenue=+11.1%
[Analyst] Revisions Ratio: +0.09 (6 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 9.4% - Earnings Yield 6.1%)
[Growth] Growth Spread = +2.7% (Analyst 6.0% - Implied 3.3%)